Hisamitsu Pharmaceutical Co Inc
[Hisamitsu Pharmaceutical] Notice of Delisting Due to Share Consolidation | May 2026
Hisamitsu Pharmaceutical announced that it approved the share consolidation at an extraordinary general meeting of shareholders held on April 17, 2026, and will delist from the Tokyo, Nagoya, and Fukuoka Stock Exchanges on May 11, 2026. For details, please refer to the press release issued on the same date.
Key Figures
- Delisting date: 2026-05-11
- Extraordinary general meeting date: 2026-04-17
- Target exchanges: Tokyo Stock Exchange, Nagoya Stock Exchange, Fukuoka Stock Exchange
AI要約
Overview of Business Performance
This document is an announcement regarding Hisamitsu Pharmaceutical's share consolidation and delisting. The proposal for share consolidation was approved at the extraordinary general meeting held on April 17, 2026, and consequently, the company will delist from the Tokyo Stock Exchange, Nagoya Stock Exchange, and Fukuoka Stock Exchange as of May 11, 2026. It does not include detailed financial figures or trends, nor does it contain information about future business outlook or financial condition.
Impact on Shareholders and Future Outlook
Delisting may lead to changes in liquidity and trading environment for shares. The company expressed gratitude to long-term shareholders and stated its commitment to enhancing corporate value, but did not specify any particular business strategies or financial improvement measures. Investors should monitor the company's future developments and potential re-listing prospects.
Hisamitsu Pharmaceutical, Inc.
Company overview · Stock price · Financial data · All IR
